Table 2 Cox proportional hazard analysis.

From: HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients

 

Discharged alive

Becoming non-infective

In-hospital death

HR (95% CI), p

HR (95% CI), p

HR (95% CI), p

Age (10 years)

0.98 (0.90–1.07), 0.616

1.03 (0.95–1.12), 0.522

1.44 (1.06–1.97), 0.021

Previous history of TB treatment

1.18 (0.72–1.95), 0.506

0.90 (0.56–1.45), 0.670

2.50 (1.03–6.03), 0.042

Diabetes

0.87 (0.58–1.29), 0.479

1.04 (0.70–1.55), 0.853

1.25 (0.44–3.61), 0.675

Chronic cardiac disease

0.90 (0.57–1.44), 0.668

1.16 (0.77–1.75), 0.485

2.06 (1.04–4.09), 0.037

Insulin before admission

1.23 (0.52–2.88), 0.637

1.10 (0.48–2.54), 0.815

1.14 (0.12–11.31), 0.909

Total protein (1 g/dL)

1.04 (0.84–1.29), 0.690

0.96 (0.80–1.16), 0.688

0.75 (0.50–1.12), 0.160

Albumin (1 g/dL)

2.32 (1.79–3.02), <0.001

1.88 (1.47–2.39), <0.001

0.13 (0.06–0.26), <0.001

Creatinine (1 mg/dL)

1.08 (0.96–1.21), 0.205

0.99 (0.87–1.11), 0.835

1.12 (0.90–1.04), 0.310

HbA1c (1%)

1.03 (0.89–1.20), 0.659

0.93 (0.80–1.06), 0.277

0.68 (0.43–1.07), 0.097

Blood glucose (10 mg/dL)

0.99 (0.95–1.03), 0.598

1.02 (0.98–1.05), 0.337

0.99 (0.93–1.06), 0.779

HRE regimen

0.67 (0.45–1.00), 0.049

1.03 (0.71–1.50), 0.867

0.81 (0.37–1.77), 0.596

  1. HR: hazard ratio. HRE regimen: isoniazid, rifampicin, and ethambutol regimen was compared using isoniazid, rifampicin, pyrazinamide, and ethambutol as a reference.
Back to article page